Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorders
Title of Study: Assessment of the Impact of Art-Based Pain Assessment Tool on Pain Communication, Joint Function, and Anxiety in Patients with Temporomandibular Disorders (TMD): A Randomized Controlled Trial Location: King Abdulaziz University Dental Hospital (KAUFD), Jeddah, Saudi Arabia What Is This Study About? This
| Condition(s) | Temporomandibular Disorders (TMD), Wilkes 1 and 2, TMJ Pain, TMJ - Oral &Amp;Maxillofacial Surgery, Art Therapy, TMD Art Pain Study |
|---|---|
| Status | Recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Summary | Title of Study: Assessment of the Impact of Art-Based Pain Assessment Tool on Pain Communication, Joint Function, and Anxiety in Patients with Temporomandibular Disorders (TMD): A Randomized Controlled Trial Location: King Abdulaziz University Dental Hospital (KAUFD), Jeddah, Saudi Arabia What Is This Study About? This study examines how an art-based tool can help improve communication and understanding of pain among patients with jaw joint disorders (TMD). It compares two groups: * Standard care: Routine diagnostic and therapeutic procedures * Intervention: Standard care plus a guided art-based tool using paintings to express and discuss the TMD experiences What Is the Art-Based Tool? This novel method, called the Artistic Pain Exploration (APE), uses paintings to help patients describe t |
| Who can participate | Inclusion Criteria: * Adults aged 18 years or older * Diagnosed with Temporomandibular Disorders (TMD) requiring conservative management only and classified as Wilkes' stage I or II * Able to understand and sign the informed consent form Exclusion Criteria: * Patients requiring surgical intervention for TMD * Presence of severe mental illness, such as psychotic disorders or bipolar affective disorders * Regular use of narcotic (opioid) pain medications |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | King Abdulaziz University |
| Locations | Jeddah, Mecca Region, Saudi Arabia |
| Start date | 2025-04-25 |
| NCT ID | NCT07018791 |
| Official listing | https://clinicaltrials.gov/study/NCT07018791 |